First Manhattan’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

First Manhattan’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	–	–	1756
2022 Q3	$0	Hold	100	–	–	﹤0.01%	1605
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	1490
2022 Q1	$2K	Buy	+100	New	+$2.18K	﹤0.01%	1485

Other funds holding MSOS

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ZIG

Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Manhattan's MSOS Position: Q4 2022 in Review

First Manhattan sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2022, closing a stake of 100 shares.

First Manhattan first reported a position in MSOS in Q1 2022 and held it in 3 quarters. The position peaked at $2K in Q1 2022. 176 funds tracked by Wall St. Rank hold MSOS as of Q4 2022.

First Manhattan reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2022 after selling out during the quarter.
First Manhattan sold 100 AdvisorShares Pure US Cannabis ETF shares in Q4 2022.
First Manhattan first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2022 and held it in 3 quarters.
First Manhattan's AdvisorShares Pure US Cannabis ETF position peaked at $2K in Q1 2022.
176 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.